isoxazolin-5-one : An isoxazole that is 3-isoxazoline substituted at position 5 by an oxo group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 170745 |
| CHEBI ID | 76851 |
| MeSH ID | M0060548 |
| Synonym |
|---|
| isoxazolin-5-one |
| 2h-1,2-oxazol-5-one |
| 5(2h)-isoxazolone |
| 43228-53-1 |
| 82357-80-0 |
| 5-isoxazolol |
| 3-isoxazolin-5-one |
| CHEBI:76851 |
| 1,2-oxazol-5(2h)-one |
| 5-isoxazolone |
| C20891 |
| 5-hydroxyisoxazole |
| isoxazol-5(2h)-one |
| isoxazol-5-ol |
| DTXSID70195795 |
| Q27146375 |
| Class | Description |
|---|---|
| isoxazoles | Oxazoles in which the N and O atoms are adjacent. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (12.50%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||